Rein Therapeutics, Inc. (RNTX) earnings
RNTX earnings moved a median of -2.80% by the close. Quarterly and annual RNTX reports and results, each read against the price at its own news timestamp. Back to the RNTX overview →
12 measured RNTX earnings events.
Where these RNTX earnings landedvs 12 measured RNTX earnings reactions
| Middle 50% of RNTX earnings reactions | -5.63% to -0.17% |
|---|---|
| Median reaction (to close) | -2.80% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 RNTX earnings events with a measured close landed between -5.63% and -0.17%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Rein Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.60% | -0.49% | |
| Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -0.60% | -0.49% | |
| Form 10-Q Rein Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.91% | -4.54% | |
| Form 10-K/A Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -9.15% | |
| Form 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -7.21% | +0.81% | |
| Form 10-Q Rein Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.42% | +0.81% | |
| Form 10-Q Rein Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.87% | +3.83% | |
| Form 10-Q Rein Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.91% | |
| Rein Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -3.91% | |
| Form 10-K/A Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -8.89% | |
| Form 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -19.19% | |
| Form NT 10-K Rein Therapeutics, Inc. For: Dec 31 | SEC filing · Form NT | — | -1.69% |
Keep exploring
More RNTX: analyst actions → · SEC filings → · RNTX overview →